Healing of rectal advancement flaps for anal fistulas in patients with and without Crohn's disease: a retrospective cohort analysis.
Anal fistula
Crohn’s disease
Rectal advancement flap
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
05 Jun 2021
05 Jun 2021
Historique:
received:
15
02
2021
accepted:
26
05
2021
entrez:
5
6
2021
pubmed:
6
6
2021
medline:
9
6
2021
Statut:
epublish
Résumé
Surgical closure of anal fistulas with rectal advancement flaps is an established standard method, but it has a high degree of healing failure in some cases. The aim of this study was to identify risk factors for anal fistula healing failure after advancement flap placement between patients with cryptoglandular fistulas and patients with Crohn's disease (CD). From January 2010 to October 2020, 155 rectal advancement flaps (CD patients = 55, non-CD patients = 100) were performed. Patients were entered into a prospective database, and healing rates were retrospectively analysed. The median follow-up period was 189 days (95% CI: 109-269). The overall complication rate was 5.8%. The total healing rate for all rectal advancement flaps was 56%. CD patients were younger (33 vs. 43 years, p < 0.001), more often female (76% vs. 30%, p < 0.001), were administered more immunosuppressant medication (65% vs. 5%, p < 0.001), and had more rectovaginal fistulas (29% vs. 8%, p = 0.001) and more protective stomas (49% vs. 2%, p < 0.001) than patients without CD. However, no difference in healing rate was noted between patients with or without CD (47% vs. 60%, p = 0.088). Patients with anal fistulas with and without Crohn's disease exhibit the same healing rate. Although patients with CD display different patient-specific characteristics, no independent factors for the occurrence of anal fistula healing failure could be determined. Trial registration Not applicable due to the retrospective study design.
Sections du résumé
BACKGROUND
BACKGROUND
Surgical closure of anal fistulas with rectal advancement flaps is an established standard method, but it has a high degree of healing failure in some cases. The aim of this study was to identify risk factors for anal fistula healing failure after advancement flap placement between patients with cryptoglandular fistulas and patients with Crohn's disease (CD).
METHODS
METHODS
From January 2010 to October 2020, 155 rectal advancement flaps (CD patients = 55, non-CD patients = 100) were performed. Patients were entered into a prospective database, and healing rates were retrospectively analysed.
RESULTS
RESULTS
The median follow-up period was 189 days (95% CI: 109-269). The overall complication rate was 5.8%. The total healing rate for all rectal advancement flaps was 56%. CD patients were younger (33 vs. 43 years, p < 0.001), more often female (76% vs. 30%, p < 0.001), were administered more immunosuppressant medication (65% vs. 5%, p < 0.001), and had more rectovaginal fistulas (29% vs. 8%, p = 0.001) and more protective stomas (49% vs. 2%, p < 0.001) than patients without CD. However, no difference in healing rate was noted between patients with or without CD (47% vs. 60%, p = 0.088).
CONCLUSIONS
CONCLUSIONS
Patients with anal fistulas with and without Crohn's disease exhibit the same healing rate. Although patients with CD display different patient-specific characteristics, no independent factors for the occurrence of anal fistula healing failure could be determined. Trial registration Not applicable due to the retrospective study design.
Identifiants
pubmed: 34088303
doi: 10.1186/s12893-021-01282-4
pii: 10.1186/s12893-021-01282-4
pmc: PMC8178918
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
283Références
Dis Colon Rectum. 2009 Jan;52(1):18-22
pubmed: 19273951
Dis Colon Rectum. 2011 Dec;54(12):1537-41
pubmed: 22067182
Int J Colorectal Dis. 2017 May;32(5):599-609
pubmed: 28247060
Colorectal Dis. 2019 Jan;21(1):66-72
pubmed: 30199606
Dis Colon Rectum. 2014 Aug;57(8):1007-11
pubmed: 25003296
ANZ J Surg. 2015 Oct;85(10):720-7
pubmed: 25997475
Br J Surg. 2009 Jun;96(6):608-12
pubmed: 19402190
Gastroenterol Clin North Am. 2017 Sep;46(3):463-480
pubmed: 28838409
Dis Colon Rectum. 2002 Dec;45(12):1616-21
pubmed: 12473884
Int J Colorectal Dis. 2018 Jul;33(7):911-918
pubmed: 29651553
Dis Colon Rectum. 1992 Nov;35(11):1066-71
pubmed: 1425051
Dis Colon Rectum. 2008 Oct;51(10):1475-81
pubmed: 18626715
Int J Surg. 2019 Sep;69:153-164
pubmed: 31400504
Updates Surg. 2018 Dec;70(4):485-490
pubmed: 29982963
BJS Open. 2019 Jan 21;3(3):231-241
pubmed: 31183438
Inflamm Bowel Dis. 2019 May 4;25(6):1054-1060
pubmed: 30346531
BJS Open. 2017 Oct 17;1(3):55-66
pubmed: 29951607
Z Gastroenterol. 2014 May;52(5):436-40
pubmed: 24824908
World J Surg. 2017 Sep;41(9):2395-2400
pubmed: 28337531
Stem Cell Res Ther. 2020 Mar 17;11(1):124
pubmed: 32183875
Surg Laparosc Endosc Percutan Tech. 2019 Aug;29(4):e53-e56
pubmed: 31259866
Br J Surg. 2009 Jun;96(6):675-9
pubmed: 19434701
Am J Gastroenterol. 2000 Apr;95(4):1021-6
pubmed: 10763954
Dis Colon Rectum. 2004 Nov;47(11):1874-82
pubmed: 15622580
J Crohns Colitis. 2020 Jul 9;14(6):757-763
pubmed: 31696918
Clin Colon Rectal Surg. 2019 Jul;32(4):261-267
pubmed: 31275072
Dig Dis Sci. 2017 Aug;62(8):2079-2086
pubmed: 28550490
Clin Colon Rectal Surg. 2013 Jun;26(2):90-9
pubmed: 24436656
Am J Surg. 1999 Oct;178(4):337-40
pubmed: 10587195
Int J Colorectal Dis. 2019 Oct;34(10):1653-1660
pubmed: 31446480
BMC Gastroenterol. 2011 May 23;11:61
pubmed: 21605391
Int J Colorectal Dis. 2017 Apr;32(4):583-585
pubmed: 27878618
Br J Surg. 1995 May;82(5):603-6
pubmed: 7613925
Clin Colon Rectal Surg. 2019 Jul;32(4):273-279
pubmed: 31275074
Tech Coloproctol. 2020 Aug;24(8):833-841
pubmed: 32537672
Int J Colorectal Dis. 2015 May;30(5):595-603
pubmed: 25566951
Int J Colorectal Dis. 2019 Jan;34(1):197-200
pubmed: 30187157
Colorectal Dis. 2008 Oct;10(8):747-55; discussion 755-6
pubmed: 18462243